How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
34
MLSS Quote, Financials, Valuation and Earnings
Last price:
$0.29
Seasonality move
:
15.31%
Day range:
$0.28 - $0.30
52-week range:
$0.22 - $1.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.55x
P/B ratio:
8.67x
Volume:
41.7K
Avg. volume:
453.1K
1-year change:
-78.05%
Market cap:
$22.1M
Revenue:
$8.6M
EPS (TTM):
-$0.08
Analysts' Opinion
-
Consensus RatingMilestone Scientific, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1.00, Milestone Scientific, Inc. has an estimated upside of 255.87% from its current price of $0.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.00 representing 100% downside risk from its current price of $0.28.
Fair Value
-
According to the consensus of 1 analyst, Milestone Scientific, Inc. has 255.87% upside to fair value with a price target of $1.00 per share.
MLSS vs. S&P 500
-
Over the past 5 trading days, Milestone Scientific, Inc. has underperformed the S&P 500 by -7.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Milestone Scientific, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Milestone Scientific, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Milestone Scientific, Inc. reported revenues of $2.4M.
Earnings Growth
-
Milestone Scientific, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Milestone Scientific, Inc. reported earnings per share of -$0.01.
Enterprise value:
21.8M
EV / Invested capital:
--
Price / LTM sales:
2.55x
EV / EBIT:
--
EV / Revenue:
2.44x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
-5.17x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$6.3M
Return On Assets:
-71.54%
Net Income Margin (TTM):
-74.67%
Return On Equity:
-142.42%
Return On Invested Capital:
-125.67%
Operating Margin:
-48.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $9.8M | $8.9M | $8.9M | $2.5M | $2.4M | |
| Gross Profit | $6.3M | $6.4M | $6.3M | $1.8M | $1.6M | |
| Operating Income | -$7.1M | -$6.7M | -$6.7M | -$1.5M | -$1.1M | |
| EBITDA | -$7M | -$6.6M | -$6.5M | -$1.4M | -$1.1M | |
| Diluted EPS | -$0.10 | -$0.06 | -$0.08 | -$0.02 | -$0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $19.2M | $14.5M | $10M | $10.7M | $8.1M | |
| Total Assets | $20.1M | $15.3M | $10.6M | $11.2M | $8.5M | |
| Current Liabilities | $3.5M | $3.7M | $3.3M | $3.8M | $5M | |
| Total Liabilities | $4M | $4.1M | $3.6M | $4M | $5.9M | |
| Total Equity | $16M | $11.2M | $7M | $7.2M | $2.5M | |
| Total Debt | $528.6K | $431.3K | $321.7K | $198.7K | $927K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$5.2M | -$2.7M | -$4.2M | -$973.9K | $81.8K | |
| Cash From Investing | -$2.5M | $2.5M | -$15.5K | -- | -$6.2K | |
| Cash From Financing | -$8.5K | $2.8M | $787.2K | -$2.6K | -$4.6K | |
| Free Cash Flow | -$5.2M | -$2.7M | -$4.2M | -$973.9K | $75.6K | |
MLSS
Sector
Market Cap
$22.1M
$24.3M
Price % of 52-Week High
20.82%
50%
Dividend Yield
0%
0%
Shareholder Yield
-0.4%
-1.67%
1-Year Price Total Return
-78.05%
-21.43%
Beta (5-Year)
0.891
0.484
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.29
200-day SMA
Sell
Level
$0.58
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.29
Relative Strength Index (RSI14)
Sell
Level
43.24
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-31.556
50-day SMA
Sell
Level
$0.31
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.68)
Sell
CA Score
(Annual)
Level (-2.3157)
Buy
Beneish M-Score
(Annual)
Level (-3.4539)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (4.6115)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.
Stock Forecast FAQ
In the current month, MLSS has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MLSS average analyst price target in the past 3 months is $1.00.
-
Where Will Milestone Scientific, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Milestone Scientific, Inc. share price will rise to $1.00 per share over the next 12 months.
-
What Do Analysts Say About Milestone Scientific, Inc.?
Analysts are divided on their view about Milestone Scientific, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Milestone Scientific, Inc. is a Sell and believe this share price will drop from its current level to $1.00.
-
What Is Milestone Scientific, Inc.'s Price Target?
The price target for Milestone Scientific, Inc. over the next 1-year time period is forecast to be $1.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MLSS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Milestone Scientific, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of MLSS?
You can purchase shares of Milestone Scientific, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Milestone Scientific, Inc. shares.
-
What Is The Milestone Scientific, Inc. Share Price Today?
Milestone Scientific, Inc. was last trading at $0.29 per share. This represents the most recent stock quote for Milestone Scientific, Inc.. Yesterday, Milestone Scientific, Inc. closed at $0.28 per share.
-
How To Buy Milestone Scientific, Inc. Stock Online?
In order to purchase Milestone Scientific, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get MLSS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MLSS
Sector
P/E ratio
--
23.33x
PEG ratio
-0.09x
-0.01x
P/B ratio
8.67x
1.78x
Price / LTM sales
2.55x
1.53x
Growth Metrics
MLSS
Sector
Revenue growth
-6.11%
4%
Earnings growth
23.5%
11.06%
Revenue (5-year growth)
0.6%
6.22%
Earnings forecast
-$0.02
-$0.19
Profitability
MLSS
Sector
Profitability FY 2024
$6.4M
$3M
Return on invested capital
-125.67%
-33.25%
Return on assets
-71.54%
-29.67%
Return on equity
-142.42%
-38.89%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Feb
12
Balance Sheet
MLSS
Sector
Total cash
$1.3M
$25M
Short term investments
--
$24.9M
Total assets
$9.8M
$72.5M
Long term debt
$927K
$2.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
40
GDXU alert for Jan 31
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Sell
34
PFSI alert for Jan 31
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Sell
40
SHNY alert for Jan 31
MicroSectors Gold 3X Leveraged ETN [SHNY] is down 31.56% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
